Skip to main content

Proposed rule updates for the Radiation Oncology Model

The new Radiation Oncology alternative payment model will start Jan. 1, 2022, after the proposal is finalized in the calendar year 2022 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule, scheduled for early November. This rule will require prospective hospital outpatient departments, physician practices and freestanding clinics providing radiation therapy services to adopt a prospective bundled payment model with new clinical and quality measure reporting requirements.

The model is mandatory for participants selected by CMS.

The new RO model includes several notable changes that must be addressed for successful participation:

Disease sites update

The criteria for cancer types have been clarified. Cancer types must be:

  • commonly treated with radiation therapy according to nationally recognized evidence-based guidelines;
  • associated with ICD-10 codes that demonstrate pricing stability; and
  • not determined to be unsuitable for inclusion by the HHS Secretary.

As a result of the updated criteria, liver cancer was removed since there is limited guidance for first line use of radiotherapy for treatment. Sixteen cancer types remain included under the proposed RO Model.

Modalities of treatment update

Most radiation therapy services will be covered, including treatment planning, dose planning, radiation physicians and dosimetry, treatment devices, image guidance, special services, treatment delivery and treatment management.

Brachytherapy was removed from the list of included radiation therapy treatment modalities. The removal of this modality came out of concern for how episodes using two or more types of radiation therapy treatment would be handled and the potential disincentive its inclusion in the RO Model could create for cases where it is clinically indicated.

Performance period update:

The baseline period was updated to the CY 2017-2019 period if the model begins in 2022. This performance period impacts the calculation of national base rates and participant-specific adjustment factors that determine the professional component and technical component episode payment amounts for participants.

In addition, the discount factors were proposed to be lowered by 0.25% for each component of the model.

RO Model participant update

CMS issued a ZIP code list detailing the locations of prospective participants. These include physician group practices, freestanding centers and hospital-based outpatient departments providing radiation therapy specific episodes of care.

Several RO participant exclusions were modified:
  • Hospital outpatient departments participating in the Pennsylvania Rural Health Model will not be eligible to participate.
  • HOPDs in the Community Transformation track of the CHART Model will not be eligible to participate.
  • HOPDs in the ACO Transformation track of the CHART Model will be eligible to participate in the RO Model and CMS will apply the same overlap policy that has been proposed for MSSP ACOs.

Exclusion criteria update

An extreme and uncontrollable circumstances policy is proposed for the RO Model, allowing flexibilities to reduce administrative burdens associated with participating in the model when there is an extreme or uncontrollable circumstance affecting an entire region or locale. This allows CMS to amend the model performance period, eliminate or delay reporting requirements or amend the pricing methodology under the RO Model when there is an extreme or uncontrollable circumstance declared impacting a provider’s ability to deliver care according to the model requirements.

How to prepare

To ensure successful participation, healthcare providers must begin planning now for these proposed rule updates, new quality measures and reporting requirements. Learn how DataGen can help your practice prepare for this new alternative payment model through Performance Period Monitoring for Alternative Payment Models.

Comments

Popular posts from this blog

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit

BPCI Advanced Model Extension

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model.  The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025.  New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7.  New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that: the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%;  the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%; the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital ou

You’ve been accepted to the Enhancing Oncology Model. Now what?

The Centers for Medicare and Medicaid Services Innovation Center recently announced approved applicants for the new Enhancing Oncology Model. If your facility has been selected by CMS, are you still weighing your options during the current baseline evaluation period?  Two deciding factors may include the program data that CMS provides and whether EOM is enough of an improvement over the prior Oncology Care Model to make your investment worthwhile. Another factor to consider: Will you have the resources in place to conduct a baseline evaluation before EOM’s program start on July 1, 2023? How EOM differs from OCM EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment. It includes three major updates: Fewer cancer types. Compared with OCM’s 21, EOM will be limited to seven common cancer types: breast, prostate, lung, small intestine/colorectal, multiple myeloma, lymphoma and chronic le